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Open access under CC BIn optimal cases, bivalent ligands can bind with exceptionally high afﬁnity to their protein targets. How-
ever, designing optimised linkers, that orient the two binding groups perfectly, is challenging, and yet
crucial in both fragment-based ligand design and in the discovery of bisubstrate enzyme inhibitors. To
further our understanding of linker design, a series of novel bivalent S-adenosylmethionine (SAM) ana-
logues were designed with the aim of interacting with the MetJ dimer in a bivalent sense (1:1 ligand/MetJ
dimer). A range of ligands was synthesised and analyzed for ability to promote binding of the Escherichia
coli methionine repressor, MetJ, to its operator DNA. Binding of bivalent SAM analogues to the MetJ
homodimer in the presence of operator DNA was evaluated by ﬂuorescence anisotropy and the effect
of linker length and structure was investigated. The most effective bivalent ligand identiﬁed had a ﬂexible
linker, and promoted the DNA–protein interaction at 21-times lower concentration than the correspond-
ing monovalent control compound.
 2011 Elsevier Ltd. Open access under CC BY license.Bivalent ligands, in which two identical binding groups are
linked by a spacer unit, can have exceptionally high binding afﬁn-
ity, and can, consequently, be useful modulators of biological func-
tion.1 However, the optimisation of linkers between the binding
groups can be challenging, and, yet, is crucial in both fragment-
based ligand (and drug) design2 and in the discovery of bisubstrate
inhibitors.3 In this paper, we describe a series of symmetrical biva-
lent ligands that was prepared to extend our understanding of the
effects of linker length and ﬂexibility on biological activity.
S-Adenosylmethionine (SAM, 1)4,5 was chosen as the binding
unit due to its well studied interaction with the Escherichia coli
methionine repressor, MetJ (Fig. 1). MetJ is a homodimeric DNA-
binding protein which functions in complex with two molecules
of the co-repressor, SAM. Binding of positively charged SAM mole-
cules is believed to promote binding of the repressor to its target
DNA by a unique mechanism based primarily on long-range elec-
trostatics transferred through the protein structure.6,7 The dissoci-
ation constant of the MetJ-consensus, minimum operator DNA
complex in the presence of saturating (1 mM) levels of SAM 1
has been determined to be 4 (±3) nM by ﬁlter binding studies.
However, in the absence of SAM, 1, saturation binding of the pro-
tein to the DNA was never achieved and the Kd was estimated to
be 10 lM.8x: +44 113 343 6565.
.
Y license.The design of bivalent SAM analogues started by examination of
the SAM–MetJ dimer–DNA complex crystal structure (Fig. 1).4 In
this structure, a pair of co-repressor molecules is arranged sym-
metrically with the terminal carboxyl groups 5 Å apart. When
designing the structure of bivalent SAM ligands, consideration
was given to the structures of previously identiﬁed SAM analogues
(Panel A, Fig. 2). Aza-SAM, 2, is a stable nitrogen analogue of the
(unstable9) natural co-repressor SAM, 1, which has been shown
to bind to the protein in an identical conformation.10 Previously,
we have shown that both amide formation at the carboxy terminus
of aza-SAM (to give 3) and removal of the a-NH2 group (to give 4)
do not greatly affect function.11 In contrast, quaternisation of the
50-position amine of 4, to give the charged analogue 5, signiﬁcantly
improved activity.11 A range of bivalent SAM derivatives was,
therefore, designed in which secondary amides were used to link
two aza-SAM analogues (Panel B, Fig. 2). The optimal separation
of the terminal carbons in the linkers of such bivalent ligands
may be estimated by analysis of the structure of the SAM–MetJ
dimer–DNA complex. Provided that the bivalent ligands interact
with MetJ analogously to SAM, and that the secondary amides
adopt the preferred12 syn conformation, the optimal separation of
the terminal carbons of the linker is 5.3 Å. The proposed interac-
tion of an exemplar bivalent ligand to the MetJ dimer, in which a
simple linker bridges between the binding units, is shown in Panel
C, Figure 2. It was proposed to optimise the bivalent analogues by
varying the length and ﬂexibility of the linker and by investigating
the effect of quaternisation.
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Figure 1. Co-crystal structure of two molecules of co-repressor SAM, 1, bound on the surface of the MetJ dimer and the chemical structure of SAM.
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linkers, for example linkers based on 7a and 7b (Scheme 1) in
which the benzylic carbon atoms are separated by 5.8 and 5.0 Å
respectively. Accordingly, coupling of the carboxylic acid 6 with
the diamines 7a and 7b gave the bivalent derivatives 8a and 8b
in 68% and 66% yield respectively; unfortunately, partial (20%)
epimerization, a to the carbonyl group, occurred under the reac-
tion conditions (Scheme 1).
The intermediates 8 were exploited in the synthesis of two
different analogue classes. Acid-catalyzed deprotection gave theO
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Figure 2. Design of bivalent ligands. (A) Monovalent ligands for the MetJ dimer. (B) Des
carbon atoms in the linker was expected to be 5.3 Å. (C) Illustration of the possible i
example, a simple linker joins the terminal carboxyls of two binding units analogues vicorresponding unquaternised ligands 9a,b; alternatively, methyla-
tion and deprotection afforded the quaternised derivatives 10a,b
(Scheme 2). The bivalent ligands 9c–e (Fig. 3 and Supplementary
data) and the monovalent benzyl amides 11 and 12 were also pre-
pared (Fig. 4 and Supplementary data).
It was also decided to prepare a series of bivalent ligands with
more ﬂexible linkers in which the length of the linker was varied
more widely (see Scheme 3). The a-NH2 group was omitted for this
series, both because this group has only a small11 effect on the
function of monovalent amides (e.g., 3) and because of the epimer-3
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Scheme 2. Synthesis of the bivalent ligands 9a,b and 10a,b.
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Scheme 1. The intermediates 8a and 8b were prepared by coupling the carboxylic acid 6 and the diamines 7 (PyBOP, iPr2NEt, DMF); partial (ca. 20%) epimerization was
observed and all bivalent derivatives were consequently isolated as mixtures of diastereoisomers.
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‘click’ reaction15 between the azides 13 (n = 211 and 4) and the cyc-
looctyne 1411 and acetonide removal gave the corresponding biva-
lent analogues 15 as mixtures of regioisomers. Furthermore,
reaction between the carboxylic acid11 17 and a series of a,x-dia-
mines, and deprotection, gave the bivalent analogues 18 (n = 2, 3, 4
and 6). Finally, treatment of the bivalent analogues 15 and 18 with
methyl iodide gave the corresponding quaternised derivatives 16
and 19.
A ﬂuorescence anisotropy-based binding assay was used to
compare the relative ability of SAM analogues to promote MetJ di-
mer–DNA complex formation. Since SAM has low afﬁnity for MetJ
in the absence of DNA,8,13 measurements were made in the pres-
ence of the DNA fragment F-metC, a ﬂuorescently-labeled analogue
of the shortest naturally occurring operator sequence, metC.14Titration of MetJ into a solution containing ﬁxed concentrations
of F-metC and ligand allows the change in anisotropy related to ter-
nary complex formation to be measured (Fig. 5).
The half-maximal concentration of MetJ, EC50, required to
promote complex formation was determined for each ligand. The
concentration of the ligands used was comparable to the low
millimolar SAM concentrations used in previous in vitro binding
assays, and to the estimated SAM concentration in vivo.8 The
monovalent ligands 11 and 12 (2 mM) and the bivalent ligands 9
and 10 (1 mM) all promoted the formation of the MetJ–DNA com-
plex (Table 1). The EC50 was found to be 120 ± 10 nM and
36 ± 6 nM in the presence of the unquaternised and quaternised
monovalent control ligands 11 and 12 respectively. The unquatern-
ised bivalent ligands 9a–e (1 mM) promoted complex formation up
to about threefold more effectively than the corresponding mono-
N O N
HO OH
HN
N
N N
H2N
NH2
O
NO
N
OHHO
NH
N
NN
NH2
NH2
O
N O N
HO OH
HN
N
N N
H2N
NH2
O
NO
N
OHHO
NH
N
NN
NH2
NH2
O
N O N
HO OH
HN
N
N N
H2N
NH2
O
NO
N
OHHO
NH
N
NN
NH2
NH2
O
9c
9d
9e
Figure 3. Structures of the bivalent ligands 9c–e; partial epimerization occurred during the amide formation and the subsequent derivatives were isolated as mixtures of
diastereoisomers.
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Figure 4. Structures of the monovalent ligands 11 and 12; partial epimerization occurred during the amide formation and the subsequent derivatives were isolated as
mixtures of diastereoisomers
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and 10b promoted, respectively, complex formation 2.4- and 3.6-
fold more effectively than the quaternised monovalent analogue
12. It is notable that the EC50 value of the ligand 10b was signiﬁ-
cantly lower than that of the (unstable9) co-repressor, SAM. For
these bivalent analogues with rigid linkers, the nature of the linker
did not have a profound effect on function: in each case, the EC50
values were comparable to those of the corresponding monovalent
controls (either 11 or 12) and, consequently, it is unlikely that the
linkers allow the binding groups to engage with the MetJ dimer in
a bivalent sense.
The ability of the unquaternised ligands 4, 15, and 18 (2 mM) to
promote the formation of the MetJ–DNA complex was also investi-
gated using ﬂuorescence anisotropy (Table 2). In the presence of
the monovalent ligand 4, the EC50 was 1000 ± 100 nM.11 Mixtures
of the regioisomeric triazoles 15a and 15b promoted complex for-
mation at 9- and 13-fold lower concentration than the monovalent
ligand 4 respectively. In contrast, he activity of the bivalent ligands
18—which had shorter and more ﬂexible linkers than the triazoles
15—depended critically on the length and nature of the linker; the
compound with the shortest linker—18a in which n = 2—had simi-
lar activity to the monovalent derivative 4. However, as the linker
length increased, the EC50 improved from 700 ± 50 nM (with 18a,
n = 2) to 47 ± 1 nM (with 18d, n = 6). Unfortunately, derivatives
with longer linkers (n = 9 and 12) were not soluble under the con-
ditions of the assay. The clear dependence of the activity of the li-
gands 18a–d on the length of the linker is consistent with
interaction with the MetJ dimer in a bivalent sense.
The ability of the quaternised ligands 16 and 19 (2 mM) to pro-
mote the formation of the MetJ–DNA complex was also investi-
gated using ﬂuorescence anisotropy (Table 3). The effect of the
linker length was less profound with the quaternised analogues,generating only modest improvements in afﬁnity of up to 3.5-fold.
The EC50 improved from 150 ± 10 nM with the quaternised mono-
valent analogue 5 to 42 ± 3 nM with the most active quaternised
bivalent derivative 16b.
The results obtained in this study highlight the challenges asso-
ciated with designing effective linkers in bivalent ligands. The
activity of the bivalent ligands 9 and 10, which have rather rigid
linkers, was disappointing because the ligand concentrations re-
quired to promote DNA–protein interaction were comparable to
those of the corresponding monovalent controls (11 or 12). For
effective interaction, a rigid linker must control both the spacing
and the relative orientation of the pair of binding groups: with 9
and 10, it is likely that the linker design did not allow these ligands
to engage with the MetJ dimer in a bivalent sense. However, in
sharp contrast, the activity of the bivalent ligands, 18a–d (n = 2,
3, 4, or 6) did depend critically on the length of the ﬂexible linker.
The effective length of ﬂexible linkers in bivalent ligands has been
estimated using alternative approaches including molecular
dynamics simulations16 and random walk models.17 The optimal
separation of the terminal carbons in the linkers of effective biva-
lent ligands 18 was estimated to be 5.3 Å (Fig. 1). However, the
most effective unquaternised bivalent ligand 18 had n = 6 (i.e.,
18d), reinforcing that the effective lengths of ﬂexible linkers are
much shorter than their extended lengths.
Designing symmetrical ligands which interact effectively with
their target in a bivalent sense is a difﬁcult task, as observed previ-
ously,18–20 and highlighted again by this study. Here, modest afﬁn-
ity enhancements due to bivalency were only observed when
ﬂexible linkers were exploited: in the case of 18d, a 21-fold in-
crease in activity was observed compared to its monovalent ana-
logue, 4. We, therefore, ﬁnd that simple, ﬂexible linkers are a
useful starting point in the design of bivalent ligands; once
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Figure 5. Cartoon illustrating the ﬂuorescence anisotropy assay. The SAMmolecules promote the formation of a SAM–F-metC–protein complex, with two MetJ dimers bound
to the 18 base-pair DNA duplex.
Table 1
EC50 values, that is the concentration of MetJ monomer required
to promote half-maximal formation of its complex with the F-
metC DNA, in the presence of ligands (see Scheme 2 and Fig. 3);
improvements in the activity of bivalent ligands relative to a
monovalent control are shown
Compound EC50 (nM) Fold-improvement over
monovalent control
(11 or 12)
SAM, 1 17.3 ± 0.3 —
11 120 ± 10 —
9a 61 ± 3 2.0-fold
9b 37 ± 2 3.2-fold
9c 39 ± 1 3.1-fold
9d 75 ± 4 1.6-fold
9e 111 ± 5 1.1-fold
12 36 ± 6 —
10a 15 ± 5 2.4-fold
10b 10 ± 1 3.6-fold
The concentration of the monovalent ligands 11 and 12 was
2 mM, and the concentration of the bivalent ligands 9 and 10
was 1 mM. The concentration of F-metCwas 10 nM, and the ﬁnal
concentration of DMSO was 2%. EC50 values were determined
based on an average of three titrations, ﬁtted to a sigmoidal
growth logistic model (see Supplementary data).
Table 2
EC50 values, that is the concentration of MetJ monomer required
to promote half-maximal formation of its complex with the F-
metC DNA, in the presence of ligands (see Scheme 3 and Fig. 2);
improvements in the activity of bivalent ligands relative to a
monovalent control are shown
Compound EC50 (nM) Fold-improvement over
monovalent control 4
4 1000 ± 100 —
15a (n = 2) 110 ± 6 9.1-fold
15b (n = 4) 76 ± 2 13-fold
18a (n = 2) 700 ± 50 1.4-fold
18b (n = 3) 320 ± 40 3.1-fold
18c (n = 4) 220 ± 20 4.5-fold
18d (n = 6) 47 ± 1 21-fold
The concentration of the ligands was 2 mM and the concentra-
tion of F-metCwas 10 nM. EC50 values were determined based on
an average of three titrations, ﬁtted to a sigmoidal growth
logistic model (see Supplementary data).
Table 3
EC50 values, that is the concentration of MetJ monomer required to promote half-
maximal formation of its complex with the F-metC DNA, in the presence of ligands
(see Scheme 3 and Fig. 2); improvements in the activity of bivalent ligands relative to
a monovalent control are shown
Compound EC50 (nM) Fold-improvement over monovalent control 5
5 150 ± 10 —
16a (n = 2) 50 ± 6 3.0-fold
16b (n = 4) 42 ± 3 3.6-fold
19b (n = 3) 108 ± 3 1.4-fold
19d (n = 6) 51 ± 2 2.9-fold
The concentration of the ligands was 2 mM and the concentration of F-metC was
10 nM. EC50 values were determined based on an average of three titrations, ﬁtted
to a sigmoidal growth logistic model (see Supplementary data).
C. Joce et al. / Bioorg. Med. Chem. Lett. 22 (2012) 278–284 283evidence of bivalent interaction with a target has been obtained
with such ligands, optimisation of the linker may subsequently
be possible. The development of strategies for designing effective
linkers remains an important challenge, however, because of the
large afﬁnity enhancements that are possible with bivalent ligands
in optimal cases.Acknowledgments
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